IHC - P504S(Racemase)

The IHC – P504S (Racemase / AMACR) test is a specialized immunohistochemistry (IHC) diagnostic test used to detect Alpha-Methylacyl-CoA Racemase (AMACR), also known as P504S, in tissue samples. This marker is widely used in pathology for the diagnosis of prostate adenocarcinoma and helps distinguish malignant prostate cells from benign prostate tissue.

AMACR is an enzyme involved in fatty acid metabolism and is overexpressed in many prostate cancer cells. Detecting P504S expression helps pathologists identify suspicious glandular cells and supports accurate diagnosis when routine histopathology findings are unclear.

The P504S test is often performed alongside basal cell markers such as p63 and High Molecular Weight Cytokeratin (HMWCK) to improve diagnostic precision and differentiate prostate carcinoma from benign mimickers.

Benefits of the Test

The P504S (Racemase) IHC test offers several important diagnostic benefits:

• Detects AMACR overexpression in prostate tissue
• Supports diagnosis of prostate adenocarcinoma
• Differentiates malignant from benign prostate glands
• Improves accuracy in difficult prostate biopsy cases
• Assists in tumor classification and grading
• Helps guide treatment planning

This test is especially valuable when microscopic evaluation alone is inconclusive.

Why Doctors Recommend This Test

Doctors recommend the P504S IHC test when prostate cancer is suspected or when prostate biopsy findings require further confirmation.

It is commonly advised for:

• Suspicious prostate biopsy samples
• Atypical small acinar proliferation (ASAP) evaluation
• Confirmation of prostate adenocarcinoma
• Cases requiring differentiation from benign lesions
• Advanced pathology assessment of prostate tumors

The results help urologists and oncologists confirm diagnosis and guide personalized treatment decisions.

Preparation Before Test

No special preparation is required from the patient. The test is performed on previously collected prostate biopsy or surgical tissue specimens.

Normal Reporting Time

The typical reporting time for the P504S IHC test is 2 to 4 working days, depending on tissue processing and laboratory workflow.

Who Should Take This Test

This test is recommended for:

• Patients with suspected prostate cancer
• Individuals with abnormal prostate biopsy findings
• Patients requiring confirmation of prostate adenocarcinoma
• Cases needing tumor classification
• Oncology patients undergoing detailed prostate pathology evaluation

The IHC P504S (Racemase / AMACR) test is a critical tool in prostate cancer diagnosis. It helps accurately identify malignant prostate cells, improves diagnostic confidence, and supports timely treatment planning for better patient outcomes.